Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
published : Yesterday entities : Johnson & johnson save search
Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2024
Published: 2024-04-16 (Just crawled : 11:00) - globenewswire.com
JNJ | $147.59 0.05% -0.18% 6.4M
|
Health Technology
| Email alert
Add to watchlist
GNMSF | $282.004 -3.13% 3.83% 210
|
Health Technology
| Email alert
Add to watchlist
GMAB | $29.51 0.85% 0.85% 460K
|
Health Technology
| Email alert
Add to watchlist
darzalex sales first for
Robbins Geller Rudman & Dowd LLP, Lieff Cabraser Heimann & Bernstein LLP, and Dugan Law Firm, APLC Announce a $78 Million Class Action Settlement for Third Party Payors That Paid or Reimbursed Costs for Prescription Opioids or Treatment Related to Opioid Misuse, Addiction, and/or Overdose
Published: 2024-04-15 (Crawled : 20:00) - prnewswire.com
JNJ | $147.59 0.05% -0.18% 6.4M
|
Health Technology
| Email alert
Add to watchlist
opioid million treatment for
AviadoBio Announces First Patient Treated in ASPIRE-FTD Clinical Trial Evaluating AVB-101 for Frontotemporal Dementia with GRN Mutations
Published: 2024-04-15 (Crawled : 12:00) - biospace.com/
JNJ | $147.59 0.05% -0.18% 6.4M
|
Health Technology
|
| O: 0.1%
H: 0.75%
C: -0.53%
avb-101 first dementia for trial
Gastrointestinal Therapeutics and Diagnostics: Propelling Global Markets with Cutting-Edge Technologies by BCC Research LLC
Published: 2024-04-15 (Crawled : 11:00) - prnewswire.com
SNYNF | $92.966 0.07% -2.18% 630
|
Health Technology
|
| O: -0.53%
H: 0.61%
C: 0.61%
JNJ | $147.59 0.05% -0.18% 6.4M
|
Health Technology
|
| O: 0.1%
H: 0.75%
C: -0.53%
ABBV | $161.67 -0.38% -0.19% 3.4M
|
Health Technology
|
| O: 0.13%
H: 0.11%
C: -1.73%
SNY | $46.24 0.68% 0.63% 1.6M
|
Health Technology
|
| O: 1.95%
H: 0.0%
C: 0.0%
research global gastrointestinal therapeutics
DIGITAL THERAPEUTICS STARTUP RESPIREE™ ANNOUNCES INCORPORATION IN US WITH RESIDENCY AT JLABS @ SAN FRANCISCO
Published: 2024-04-15 (Crawled : 07:00) - prnewswire.com
JNJ | $147.59 0.05% -0.18% 6.4M
|
Health Technology
|
| O: 0.1%
H: 0.75%
C: -0.53%
therapeutics
Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Co...
Published: 2024-04-15 (Crawled : 06:00) - biospace.com/
JNJ | $147.59 0.05% -0.18% 6.4M
|
Health Technology
|
| O: 0.1%
H: 0.75%
C: -0.53%
XOMA | $24.34 -5.84% -4.49% 6.1K
|
Health Technology
|
| O: -2.63%
H: 1.39%
C: -3.3%
biopharma platform
Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Companies
Published: 2024-04-15 (Crawled : 06:00) - biospace.com/
JNJ | $147.59 0.05% -0.18% 6.4M
|
Health Technology
|
| O: 0.1%
H: 0.75%
C: -0.53%
XOMA | $24.34 -5.84% -4.49% 6.1K
|
Health Technology
|
| O: -2.63%
H: 1.39%
C: -3.3%
companies biopharma platform
Gainers vs Losers
| 45% | 55% |
Top 10 Gainers
KAVL | $6.3 135.96% 57.45% 44M
|
Wholesale Trade
PXMD | $0.74 79.7% 44.16% 4.5M
|
Health Technology
DYNT | $0.3704 -5.27% 43.09% 5.5M
|
Health Technology
LGVN P 3 d | $2.93 73.37% 42.52% 56M
|
HUBC | $1.95 50.0% 32.99% 73M
|
n/a
SPCB | $0.4004 45.07% 31.75% 130M
|
Electronic Technology
ONVO | $1.35 33.65% 24.62% 53M
|
Health Technology
OMQS | $0.7038 35.35% 24.3% 3.5M
|
Professional, Scientific, and T...
SNPO | $10.54 29.48% 22.88% 3.9M
|
EEIQ | $1.16 27.46% 20.86% 6.9K
|
Educational Services
Your saved searches
Save your searches and get alerts when important news are released.